The Problem of Anaphylaxis and Mastocytosis

被引:24
作者
Mueller, Ulrich R. [1 ]
Haeberli, Gabrielle [1 ]
机构
[1] Spitalnetzbern, Spital Ziegler, Dept Med, Div Allergy, CH-3007 Bern, Switzerland
关键词
INDOLENT SYSTEMIC MASTOCYTOSIS; HYMENOPTERA VENOM ALLERGY; BASAL SERUM TRYPTASE; MAST-CELL TRYPTASE; FATAL ANAPHYLAXIS; IMMUNOTHERAPY; SEVERITY; CLASSIFICATION; EPIDEMIOLOGY; SYMPTOMS;
D O I
10.1007/s11882-009-0010-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Mastocytosis is a rare disease characterized by an elevated whole body mast cell number. Anaphylaxis is a severe, generalized hypersensitivity reaction with rapid onset. The problem of anaphylaxis and mastocytosis is due to strongly increased mediator release from the elevated mast cell number during allergic reactions. This explains the much higher prevalence of anaphylaxis in mastocytosis than in the general population and its severe and sometimes fatal course. Because of the increased risk of anaphylaxis in mastocytosis, all patients with severe or recurrent anaphylaxis should be analyzed for underlying mastocytosis by estimation of baseline serum tryptase. If this is elevated, patients also should be tested via skin examination for cutaneous mastocytosis and with a bone marrow biopsy. All patients with mastocytosis and anaphylaxis must be instructed about avoiding the responsible elicitors and should carry an emergency kit with adrenaline for self-application. In mastocytosis patients with anaphylaxis due to Hymenoptera stings, venom immunotherapy is recommended for life.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 48 条
[1]   Systemic mastocytosis [J].
Akin, C ;
Metcalfe, DD .
ANNUAL REVIEW OF MEDICINE, 2004, 55 :419-432
[2]   Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization [J].
Bohlke, K ;
Davis, RL ;
DeStefano, F ;
Marcy, SM ;
Braun, MM ;
Thompson, RS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (03) :536-542
[3]   Allergen specific immunotherapy is safe and effective inpatients with systemic mastocytosis and Hymenoptera, allergy [J].
Bonadonna, Patrizia ;
Zanotti, Roberta ;
Caruso, Beatrice ;
Castellani, Luca ;
Perbellini, Oinar ;
Colarossi, Sabrina ;
Chilosi, Marco ;
Dania, Annarita ;
Schiaploli, Michele ;
Pizzolo, Giovanni ;
Senna, Gianenrico ;
Passalacqua, Gioianni .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (01) :256-257
[4]   Prevention and treatment of hymenoptera venom allergy:: guidelines for clinical practice [J].
Bonifazi, F ;
Jutel, M ;
Biló, BM ;
Birnbaum, J ;
Muller, U .
ALLERGY, 2005, 60 (12) :1459-1470
[5]  
BRESSER H, 2005, ALLERGO J, V7, P373
[6]   Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients [J].
Brockow, K. ;
Jofer, C. ;
Behrendt, H. ;
Ring, J. .
ALLERGY, 2008, 63 (02) :226-232
[7]   Surrogate markers for severity of systemic mastocytosis [J].
Brockow, Knut .
ALLERGO JOURNAL, 2006, 15 (04) :273-279
[8]  
Castells MC, 2004, ALLERGY ASTHMA PROC, V25, P33
[9]   Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain:: a study of the Spanish network on mastocytosis (REMA) [J].
de Olano, D. Gonzalez ;
Caballer, B. de la Hoz ;
Lopezz, R. Nunez ;
Munozz, L. Sanchez ;
Agustin, M. Cuevas ;
Dieguez, M. C. ;
Twose, I. Alvarez ;
Castells, M. C. ;
Mora, L. Escribano .
CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (10) :1547-1555
[10]   Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis [J].
De Olano, David Gonzalez ;
Alvarez-Twose, Ivan ;
Esteban-Lopez, Maria I. ;
Sanchez-Munoz, Laura ;
Durana, Maria D. Alonso Diaz ;
Vega, Arantza ;
Garcia-Montero, Andres ;
Gonzalez-Mancebo, Eloina ;
Belver, Teresa ;
Herrero-Gil, Maria D. ;
Fernandez-Rivas, Montserrat ;
Orfao, Alberto ;
de la Hoz, Belen ;
Castells, Mariana C. ;
Escribano, Luis .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) :519-526